Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Occlusion Devices Market Growth From $4.6 Billion In 2026 To $6.54 Billion By 2030 At A CAGR Of 9.2%
The occlusion devices market size has demonstrated substantial growth in recent years. It is projected to expand from $4.2 billion in 2025 to $4.6 billion in 2026, registering a compound annual growth rate (CAGR) of 9.6%. This historical expansion can be ascribed to factors such as a rise in cardiovascular diseases, advancements in interventional radiology, an increasing aging population, the expansion of hospital infrastructure, and the broader clinical adoption of embolization procedures.
The occlusion devices market size is expected to experience robust growth over the next few years. It is forecast to grow to $6.54 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.2%. This growth throughout the forecast period is driven by an increase in neurological disorders, the rising number of minimally invasive surgeries, advancements in device technology, the expansion of ambulatory care centers, and favorable reimbursement policies. Prominent trends for the forecast period include a shift towards minimally invasive procedures, a greater adoption of catheter-based therapies, an increasing preference for embolization procedures, growth in neurovascular interventions, and a demand for high-precision occlusion devices.
Get A Free Sample Report With In-Depth Market Insights:
Occlusion Devices Market Growth Momentum: What Factors Are Shaping Demand?
The increasing requirement for minimally invasive techniques is projected to drive the expansion of the occlusion devices market moving forward. Minimally invasive surgeries are defined as surgical methods that employ small cuts or existing body orifices to access and treat internal structures, organs, or tissues, minimizing damage to the patient’s body. These techniques offer medical, financial, and aesthetic advantages that are highly attractive to both patients and healthcare providers, thus fueling their growing adoption across various medical specialties. Occlusion devices are medical instruments utilized in minimally invasive procedures to block or close off blood vessels, ducts, or other pathways within the body. Such devices are frequently used in areas like interventional cardiology and radiology to address conditions including aneurysms, abnormal blood flow, or congenital heart defects. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that in 2023, the total volume of aesthetic procedures approached 35 million, with combined surgical and non-surgical procedures seeing a 3.4% increase to reach 34.9 million. Therefore, the heightened demand for minimally invasive techniques is a significant impetus for the growth of the occlusion devices market.
Occlusion Devices Market Segmentation And Category Overview
The occlusion devices market covered in this report is segmented –
1) By Product: Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices
2) By Application: Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology
3) By End User: Hospitals Diagnostic Centers And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes
Subsegments:
1) By Occlusion Removal Devices: Thrombectomy Devices, Catheter-Based Occlusion Removal Devices, Aspiration Systems, Mechanical Clot Retrieval Systems
2) By Embolization Devices: Coil Embolization Devices, Particle Embolization Devices, Balloon Embolization Devices, Gel Embolic Agents, Liquid Embolic Agents, Stent-Assisted Embolization Devices
3) By Tubal Occlusion Devices: Essure Devices, Hysteroscopic Sterilization Systems, Fallopian Tube Clips, Tubal Ligation Devices
4) By Support Devices: Occlusion Catheters, Guidewires For Occlusion, Supportive Sheaths, Stent-Grafts For Occlusion Support
Occlusion Devices Market Trends Redefining Industry Growth
Leading companies within the occlusion devices market are prioritizing the creation of innovative solutions, including advanced next-generation devices, to refine targeted embolization procedures. A next-generation device represents an updated version of existing technology, offering superior performance, enhanced features, and novel capabilities. For instance, in July 2025, Embolx, a US-based medical equipment manufacturer, launched the Sniper G3 Balloon Occlusion Microcatheter, which substantially improves targeted embolization through greater efficiency, ease of use, and an extended shelf life. This third-generation device doubles its shelf life to 24 months, providing improved inventory flexibility. Developed with direct input from interventional radiologists, it features enhanced trackability and a simplified preparation process that cuts setup time to under a minute. These improvements underscore Embolx’s dedication to physician-centered design, aimed at streamlining clinical workflows and optimizing procedural outcomes. The Sniper G3 is available in all standard lengths and is prepared for global distribution, strengthening its position as a key tool in embolization therapy.
Occlusion Devices Market Industry Leaders And Competitive Landscape
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS
View The Full Occlusion Devices Market Report:
Occlusion Devices Market Regional Analysis And Leading Geography
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
